Neuronal Signaling
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% |  |
| ATH434, is an oral agent designed to inhibit the aggregation of pathological proteins | ||||
| 24068 | Acoramidis hydrochloride | 2242751-53-5 | ≧98.0% |  |
| Acoramidis is an oral, potent, and highly selective small molecule transthyretin (TTR | ||||
| 24084 | Iclepertin (BI-425809) | 1421936-85-7 | ≧98.0% | _1421936-85-7.png) |
| Iclepertin (BI-425809) is an oral, small-molecule inhibitor of GlyT-1for the treatmen | ||||
| 24067 | PBT434 Hydrobromide | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||
| 822222 | SEP-363856 HCl ( SEP-856 ) | 1310422-41-3 (HCl) | ≧98.0% | .png) |
| SEP-363856 is a novel trace amine receptor 1 (TAAR1) agonist with serotonin 5-HT1A ac | ||||
| 230401 | Glycerol phenylbutyrate ( HPN-100 ) | 611168-24-2 | ≧98.0% | .png) |
| Glycerol phenylbutyrate, also known as HPN-100, is under trials in the treatment of c | ||||
| 24041 | ASN-90 ( ASN-120290, FNP-223 ) | 2129093-74-7 | ≧98.0% | _2129093-74-7.png) |
| ASN-90 (ASN-120290, FNP-223) is an oral, brain-penetrant, small-molecule inhibitor of | ||||
| 24042 | SPG-601 ( VSN-16R ) | 863713-78-4 | ≧98.0% |  |
| SPG-601 (formerly VSN-16R) is an orally available cannabinoid receptor agonist. | ||||